Synthetic lethal screen identification of chemosensitizer loci in cancer cells

Nature

Volumn 446, Issue 7137, 2007, Pages 815-819

  Whitehurst, Angelique W ^a   Bodemann, Brian O ^a   Cardenas, Jessica ^a   Ferguson, Deborah ^a   Girard, Luc ^a   Peyton, Michael ^a   Minna, John D ^a,b   Michnoff, Carolyn ^c   Hao, Weihua ^c   Roth, Michael G ^c   Xie, Xian Jin ^a,b   White, Michael A ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; GEMCITABINE; NAVELBINE; PACLITAXEL; PROTEASOME; SMALL INTERFERING RNA;

APOPTOSIS; CANCER; GENE EXPRESSION; GENOMICS; IDENTIFICATION METHOD; PATHOLOGY; PROTEIN; RNA;

ALGORITHM; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL VIABILITY; CHEMOSENSITIZATION; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TARGETING; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENE TARGETING; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC SCREENING; GENOME; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; LUNG CANCER; MICROTUBULE; MITOSIS; PRIORITY JOURNAL; RNA INTERFERENCE; STATISTICAL ANALYSIS;

EID: 34147198467     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05697     Document Type: Article

References (22)

1. Green, D. R. & Evan, G. I. A matter of life and death. Cancer Cell 1, 19-30 (2002).
2. Chien, Y. & White, M. A. RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep. 4, 800-806 (2003).
3. Matheny, S. A. et al. Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP. Nature 427, 256-260 (2004).
4. Malo, N., Hanley, J. A., Cerquozzi, S., Pelletier, J. & Nadon, R. Statistical practice in high-throughput screening data analysis. Nature Biotechnol. 24, 167-175 (2006).
5. Benjamini, Y. H. Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B 57, 2890300 (1995).
6. Allison, D. B., Cui, X., Page, G. P. & Sabripour, M. Microarray data analysis: from disarray to consolidation and consensus. Nature Rev. Genet. 7, 55-65 (2006).
7. Wit, E. & McClure, J. Statistical adjustment of signal censoring in gene expression experiments. Bioinformatics 19, 1055-1060 (2003).
8. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B 57, 289-300 (1995).
9. Jordan, M. A. & Wilson, L. The use and action of drugs in analyzing mitosis. Methods Cell Biol. 61, 267-295 (1999).
10. Moritz, M. & Agard, D. A. Gamma-tubulin complexes and microtubule nucleation. Curr. Opin. Struct. Biol. 11, 174-181 (2001).
11. Jordan, M. A. & Wilson, L. Microtubules as a target for anticancer drugs. Nature Rev. Cancer 4, 253-265 (2004).
12. Scanlan, M. J., Simpson, A. J. & Old, L. J. The cancer/testis genes: review, standardization, and commentary. Cancer Immun. 4, 1-15 (2004).
13. Toschi, L., Finocchiaro, G., Bartolini, S., Gioia, V. & Cappuzzo, F. Role of gemcitabine in cancer therapy. Future Oncol. 1, 7-17 (2005).
14. Weaver, B. A. & Cleveland, D. W. Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death. Cancer Cell 8, 7-12 (2005).
15. Ramirez, R. D. et al. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res. 64, 9027-9034 (2004).
16. Rieder, C. L. & Maiato, H. Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev. Cell 7, 637-651 (2004).
17. Davies, A. M. et al. Bortezomib-based combinations in the treatment of non-small-cell lung cancer. Clin. Lung Cancer 7 (Suppl 2), S59-S63 (2005).
18. Kawasaki-Nishi, S., Nishi, T. & Forgac, M. Proton translocation driven by ATP hydrolysis in V-ATPases. FEBS Lett. 545, 76-85 (2003).
19. +)-ATPases. J. Pharmacol. Exp. Ther. 297, 114-120 (2001).
20. Xie, X. S. et al. Salicylihalamide A inhibits the V0 sector of the V-ATPase through a mechanism distinct from bafilomycin A1. J. Biol. Chem. 279, 19755-19763 (2004).
21. Wu, Y., Liao, X., Wang, R., Xie, X. S. & De Brabander, J. K. Total synthesis and initial structure-function analysis of the potent V-ATPase inhibitors salicylihalamide A and related compounds. J. Am. Chem. Soc. 124, 3245-3253 (2002).
22. Skehan, P. et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl Cancer Inst. 82, 1107-1112 (1990).